<code id='D109282AA2'></code><style id='D109282AA2'></style>
    • <acronym id='D109282AA2'></acronym>
      <center id='D109282AA2'><center id='D109282AA2'><tfoot id='D109282AA2'></tfoot></center><abbr id='D109282AA2'><dir id='D109282AA2'><tfoot id='D109282AA2'></tfoot><noframes id='D109282AA2'>

    • <optgroup id='D109282AA2'><strike id='D109282AA2'><sup id='D109282AA2'></sup></strike><code id='D109282AA2'></code></optgroup>
        1. <b id='D109282AA2'><label id='D109282AA2'><select id='D109282AA2'><dt id='D109282AA2'><span id='D109282AA2'></span></dt></select></label></b><u id='D109282AA2'></u>
          <i id='D109282AA2'><strike id='D109282AA2'><tt id='D109282AA2'><pre id='D109282AA2'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:6288
          Bernard Moss, a research scientist at NIAID. -- Infectious disease coverage from STAT
          Bernard Moss Courtesy NIAID

          For more than half a century, scientist Bernard Moss has been commanding the attention of peers interested in prying biological secrets from poxviruses and other microbiological targets. Now he’s commanding the attention of a different audience: House Republicans.

          Moss, who will mark his 86th birthday in late July and who goes by Bernie, has worked for more than 55 years in the laboratories of the National Institute of Allergy and Infectious Diseases in Bethesda, Md. Over that time, he has been investigating viruses in relative anonymity — except, that is, among the virological cognoscenti.

          advertisement

          But last year, in an interview with Science, Moss said he planned to try to determine why one strain of mpox viruses, known as Clade 1, is so much more virulent than those in a second strain, Clade 2, by taking genes from the former and putting them into the latter. Clade 2 viruses are responsible for the ongoing mpox outbreak first detected in May 2022.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          BioMarin wins approval for gene therapy to treat hemophilia A
          BioMarin wins approval for gene therapy to treat hemophilia A

          AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

          read more
          'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search
          'Stay indoors': Escaped wild animal on the loose in Berlin prompts urgent citywide search

          1:30PoliceofficerscoordinatethesearchforawildanimalinaresidentialareainTeltow,Germany,ThursdayJuly20

          read more
          Bright Health sells Medicare Advantage business to Molina
          Bright Health sells Medicare Advantage business to Molina

          BrightHealthisofficiallyleavingthehealthinsurancemarket.ThecompanyhasagreedtosellitsMedicareAdvantag

          read more

          Vir antibody drug aimed at influenza A fails in clinical trial

          F.A.Murphy/CDCVirBiotechnologysaidThursdaythatalong-actingantibodydrugdesignedtoprotecthealthyindivi